NAT10 and breast cancer: In BC, NAT10 deletion decreases the mRNA stability of key fatty acid metabolism genes ELOVL6 and ACSL1 [328, 334], while the ac4C-JunB-LDHA axis activates the glycolytic pathway and contributes to an immunosuppressive microenvironment [335].